SMS Pharmaceuticals gets EIR report for facility at Bachupally, Hyderabad

From USFDA

SMS Pharmaceuticals has received Establishment Inspection Report from USFDA for its manufacturing facility - Unit II located at Bachupally, Hyderabad, Telangana. The facility was inspected in November 2017 and there were no Form 483 observations during the inspection.

Powered by Capital Market - Live News